Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

2 days Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential Seeking Alpha

Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential.

Eli Lilly (LLY)

  X     

14 hours Why the Market Dipped But Eli Lilly (LLY) Gained Today Zacks

   X     

5 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

5 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

1 week Why Eli Lilly (LLY) Dipped More Than Broader Market Today Zacks

   X     

2 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

   X     

2 weeks Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks

   X     

2 weeks Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance

   X     

2 weeks Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 weeks Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks

   X     

2 weeks Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance

   X     

2 weeks Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance

   X     

3 weeks Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance

   X     

3 weeks Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily

   X     

3 weeks Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance

   X     

3 weeks Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube

   X     

3 weeks Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com

   X     

3 weeks There’s a New Obesity King The Wall Street Journal

   X     

3 weeks Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha

   X     

3 weeks LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks

   X     

3 weeks FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com

   X     

3 weeks Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch

   X     

3 weeks Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com

   X     

3 weeks IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily

   X     

3 weeks FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC

   X     

3 weeks Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha

   X     

3 weeks Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

   X     

3 weeks Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

   X     

3 weeks Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

   X     

3 weeks NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

   X     

3 weeks 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance

   X     

3 weeks Eli Lilly: A Rare Buying Opportunity Seeking Alpha

   X     

3 weeks Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

   X     

3 weeks EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

   X     

4 weeks Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

   X     

4 weeks Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

   X     

4 weeks Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

   X     

4 weeks Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

   X     

4 weeks Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

   X     

4 weeks Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

   X     

4 weeks Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

   X     

4 weeks Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

   X     

4 weeks Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

   X     

4 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

   X     

4 weeks Eli Lilly announces $15 billion buyback, dividend hike Investing.com

   X     

4 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

   X     

4 weeks Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com

   X     

1 month Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now Yahoo Finance

   X     

1 month The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

   X     

1 month Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

   X     

1 month Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News